Page URL: https://www.bionews.org.uk/page_88768

Superman actor 'angry' at Bush

23 September 2002
By BioNews
Appeared in BioNews 176

Christopher Reeve, the American actor who once played 'Superman', has criticised the Roman Catholic Church and President Bush in an interview with the UK's Guardian newspaper.

Reeve, who was paralysed after a horse-riding accident seven years ago, claims the policies of the church and the president have 'obstructed research' - including embryonic stem cell (ES cell) research and therapeutic cloning - which might have helped him and others with spinal cord injuries to recover.

Reeve said that he was 'angry and disappointed' that the Bush administration failed to support a bill in the Senate earlier this year that would have allowed ES cell research and therapeutic cloning while banning reproductive cloning. He claimed that Bush 'caved' on the issue after the Catholic church spoke out against cloning for any purpose and the destruction of embryos in research.

Later speaking to the BBC, Reeve further stated that 'if we'd had full government support, full government funding for aggressive research using embryonic stem cells from the moment they were first isolated... I don't think it unreasonable to speculate that we might be in human trials by now.'

SOURCES & REFERENCES
Harmful moratorium on stem cell research
Science |  20 September 2002
Man of steel
The Guardian |  17 September 2002
Paralysed Reeve blames Bush and Catholic church for his plight
The Guardian |  17 September 2002
Reeve: Bush 'blocking' research
BBC News Online |  17 September 2002
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
11 October 2004 - by BioNews 
Christopher Reeve, the actor most famous for playing Superman, has died at the age of 52. Reeve was paralysed from the neck down after a horse riding accident in 1995. He recently developed a pressure sore, a common side-effect for people confined to wheelchairs, and the sore became seriously infected...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.